RUTW241216C2040000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
FOMC Likely to Cut Rates by 25bps
Another Week, Another Index Record | Lkive Stock
HC Wainwright & Co. Reiterates Buy on Viridian Therapeutics, Maintains $34 Price Target
(PCVX) - Analyzing Vaxcyte's Short Interest
Viridian Therapeutics Analyst Ratings
Analyst Ming-Chi Kuo Says "Nvidia GB300/B300 DrMOS Testing Update: Severe Thermal Issues With AOS, MPS Order Trends May Be Better-Than-Feared" - Medium
Cruise Line Preview: The 2025 Wave Season Is Expected to Be Strong for the Industry
JMP Securities Reiterates Market Outperform on Opendoor Technologies, Maintains $2.5 Price Target
MindMed Doses First Patient in Phase 3 Trial of LSD Trial for Anxiety
Opendoor Technologies Analyst Ratings
Innovative Ind Props Analyst Ratings
Wall Street's Most Accurate Analysts Give Their Take On 3 Financial Stocks Delivering High-Dividend Yields
JMP Securities Reiterates Market Perform on 1stdibs.comto Market Perform
1stdibs.com Analyst Ratings
PepGen Stock Craters 35% on FDA Clinical Hold
Crinetics Pharmaceuticals Analyst Ratings
Why Foghorn Therapeutics (FHTX) Stock Is Trading Lower
Cheesecake Factory Analyst Ratings
Immersion Non-GAAP EPS of $1.22 Beats by $0.67, Revenue of $616.2M Beats by $480.14M
Looking Into Interparfums's Recent Short Interest